UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

American journal of hematology, 2022-06, Vol.97 (6), p.700-710

2022

Volltextzugriff (PDF)

Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma

Clinical cancer research, 2017-11, Vol.23 (21), p.6602-6615

2017

Volltextzugriff (PDF)

Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin's Lymphoma Cell Lines

Materials, 2020-08, Vol.13 (15), p.3420

2020

Volltextzugriff (PDF)

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients

Journal of clinical medicine, 2021-06, Vol.10 (12), p.2683

2021

Volltextzugriff (PDF)

P848: EXPRESSION PROFILE OF BCL‐2 FAMILY PROTEINS IN MULTIPLE MYELOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e8080195-n/a

2023

Volltextzugriff (PDF)

Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells

Frontiers in pharmacology, 2024-03, Vol.15, p.1351565-1351565

2024

Volltextzugriff (PDF)

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma

International journal of molecular sciences, 2016-11, Vol.17 (12), p.2003-2003

2016

Volltextzugriff (PDF)

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients

PloS one, 2016-02, Vol.11 (2), p.e0146722-e0146722

2016

Volltextzugriff (PDF)

Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

Haematologica (Roma), 2024-03, Vol.109 (3), p.877

2024

Volltextzugriff (PDF)

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

Haematologica (Roma), 2013-04, Vol.98 (4), p.640-648

2013

Volltextzugriff (PDF)

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility

Haematologica (Roma), 2018-05, Vol.103 (5), p.880

2018

Volltextzugriff (PDF)

Factors Regulating microRNA Expression and Function in Multiple Myeloma

Non-coding RNA, 2019-01, Vol.5 (1), p.9

2019

Volltextzugriff (PDF)

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

Clinical cancer research, 2016-01, Vol.22 (1), p.207-217

2016

Volltextzugriff (PDF)

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma

Cancers, 2022-09, Vol.14 (18), p.4492

2022

Volltextzugriff (PDF)

The protective effect of silver nanoparticles' on epithelial cornea cells against ultraviolet is accompanied by changes in calcium homeostasis and a decrease of the P2X7 and P2Y2 receptors

Biomedicine & pharmacotherapy, 2024-01, Vol.170, p.116090-116090, Article 116090

2024

Volltextzugriff (PDF)

Extracellular Vesicles in Multiple Myeloma-Cracking the Code to a Better Understanding of the Disease

Cancers, 2022-11, Vol.14 (22), p.5575

2022

Volltextzugriff (PDF)

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

Journal of hematology and oncology, 2017-06, Vol.10 (1), p.127-127, Article 127

2017

Volltextzugriff (PDF)

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

Journal of hematology and oncology, 2017-04, Vol.10 (1), p.92-92, Article 92

2017

Volltextzugriff (PDF)

Capillary Nano-immunoassay for Quantification of Proteins from CD138-purified Myeloma Cells

Bio-protocol, 2019-06, Vol.9 (12), p.e3267-e3267

2019

Volltextzugriff (PDF)

Left and right ventricular global longitudinal strain assessment together with biomarker evaluation may have a predictive and prognostic role in patients qualified for hematopoietic stem cell transplantation due to hematopoietic and lymphoid malignancies - a pilot study description

Cardio-oncology (London, England), 2024-02, Vol.10 (1), p.9-9, Article 9

2024

Volltextzugriff (PDF)

Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene

Journal of biochemical and molecular toxicology, 2009-01, Vol.23 (1), p.18-28

2009

Volltextzugriff (PDF)

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

Haematologica (Roma), 2011-03, Vol.96 (3), p.468-471

2011

Volltextzugriff (PDF)

Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205

Cancer cell international, 2009-04, Vol.9 (1), p.10-10

2009

Volltextzugriff (PDF)

The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells

Toxicology in vitro, 2009-08, Vol.23 (5), p.763-771

2009

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Humans
(21)
Multiple Myeloma
(16)
Hematology
(15)
Oncology
(11)
Multiple Myeloma - Genetics
(10)
Bone Marrow
(9)
Cell Line, Tumor
(9)
Prognosis
(8)
Cancer
(7)
Mutation
(7)
Apoptosis
(6)
Biochemistry & Molecular Biology
(6)
Cell Cycle
(6)
Gene Expression
(6)
Gene Expression Regulation, Neoplastic
(6)
Medical Prognosis
(6)
Multiple Myeloma - Pathology
(6)
Proteins
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

Amiloride, An Old Diuretic Drug, Is a Potential Therapeutic Agent for Multiple Myeloma

Effect of Graphene Family Materials on Multiple Myeloma and Non-Hodgkin's Lymphoma Cell Lines

The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma Patients

P848: EXPRESSION PROFILE OF BCL‐2 FAMILY PROTEINS IN MULTIPLE MYELOMA

Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma

Microvesicles from Mesenchymal Stromal Cells Are Involved in HPC-Microenvironment Crosstalk in Myelodysplastic Patients

Quantification of cyclin D1 and D2 proteins in multiple myeloma identifies different expression patterns from those revealed by gene expression profiling

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility

Factors Regulating microRNA Expression and Function in Multiple Myeloma

Post-transcriptional Modifications Contribute to the Upregulation of Cyclin D2 in Multiple Myeloma

CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple Myeloma

The protective effect of silver nanoparticles' on epithelial cornea cells against ultraviolet is accompanied by changes in calcium homeostasis and a decrease of the P2X7 and P2Y2 receptors

Extracellular Vesicles in Multiple Myeloma-Cracking the Code to a Better Understanding of the Disease

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

Capillary Nano-immunoassay for Quantification of Proteins from CD138-purified Myeloma Cells

Left and right ventricular global longitudinal strain assessment together with biomarker evaluation may have a predictive and prognostic role in patients qualified for hematopoietic stem cell transplantation due to hematopoietic and lymphoid malignancies - a pilot study description

Sulforaphane and its analogues inhibit CYP1A1 and CYP1A2 activity induced by benzo[a]pyrene

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients

Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205

The effect of isothiocyanates on CYP1A1 and CYP1A2 activities induced by polycyclic aromatic hydrocarbons in Mcf7 cells

Suchergebnisse filtern